Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
1(20%)
Results Posted
50%(1 trials)

Phase Distribution

Ph phase_4
1
20%
Ph early_phase_1
2
40%
Ph phase_2
1
20%
Ph phase_1
1
20%

Phase Distribution

3

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution5 total trials
Early Phase 1First-in-human
2(40.0%)
Phase 1Safety & dosage
1(20.0%)
Phase 2Efficacy & side effects
1(20.0%)
Phase 4Post-market surveillance
1(20.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

5

all time

Status Distribution
Active(1)
Completed(2)
Other(2)

Detailed Status

Completed2
unknown2
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (40.0%)
Phase 11 (20.0%)
Phase 21 (20.0%)
Phase 41 (20.0%)

Trials by Status

completed240%
recruiting120%
unknown240%

Recent Activity

1 active trials
Showing 5 of 5
recruitingphase_1

Topical Netarsudil for the Prevention of Proliferative Vitreoretinopathy in Patients With Retinal Detachment

NCT06033703
completedearly_phase_1

Netarsudil Use After Descemtorhexis Without Endothelial Keratoplasty

NCT04752020
completedphase_2

A Phase 2 Study Evaluating the Safety and Efficacy of Netarsudil Ophthalmic Solution in Patients With Corneal Edema Due to Fuchs Corneal Dystrophy

NCT04498169
unknownphase_4

Intraocular Pressure Reduction Efficacy of Rhopressa and Lumigan in Normal Tension Glaucoma

NCT04981886
unknownearly_phase_1

Short-term Effect of Rho-kinase Inhibitor on Retinal Circulation

NCT04234932

Clinical Trials (5)

Showing 5 of 5 trials
NCT06033703Phase 1

Topical Netarsudil for the Prevention of Proliferative Vitreoretinopathy in Patients With Retinal Detachment

Recruiting
NCT04752020Early Phase 1

Netarsudil Use After Descemtorhexis Without Endothelial Keratoplasty

Completed
NCT04498169Phase 2

A Phase 2 Study Evaluating the Safety and Efficacy of Netarsudil Ophthalmic Solution in Patients With Corneal Edema Due to Fuchs Corneal Dystrophy

Completed
NCT04981886Phase 4

Intraocular Pressure Reduction Efficacy of Rhopressa and Lumigan in Normal Tension Glaucoma

Unknown
NCT04234932Early Phase 1

Short-term Effect of Rho-kinase Inhibitor on Retinal Circulation

Unknown

All 5 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
5